Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • The Health Equity podcast
    • Access insights
    • The Health Equity podcast
  • News
  • Our team
  • Featured insights
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

Jayasree K. Iyer to speak on solving the global healthcare inequity gap at the World EPA Congress

The Access to Medicine Foundation's CEO, Jayasree K. Iyer, will be a keynote speaker at the World Evidence, Pricing, and Access Congress in Amsterdam. Her speech will focus on the global healthcare inequality gap and how to bridge it.

Date

22 March 2023

Date

22 March 2023

Location

Amsterdam

Format

In-person

Keynote speech

Jayasree will take the stage at the World Evidence, Pricing, and Access (EPA) Congress to deliver a keynote speech titled ‘Solving the global healthcare inequity gap’. She will discuss the Foundation’s approach to change-making and share insights from the 2022 Access to Medicine Index. She will highlight industry trends, best practices, and key opportunities to communicate how healthcare companies can strengthen their strategies to increase access to medicine in low- and middle-income countries.

About the Congress

The World Evidence, Pricing, and Access Congress is Europe's largest congress attracts over 1,200 attendees from across the healthcare ecosystem. The 2023 edition will feature 300 speakers across multiple streams, exploring various topics including Real-world evidence, Health technology assessment, Medical Devices, Affordability, Digital Health, Analytics and Emerging Markets.

As a world-leading forum, EPA provides an opportunity to showcase solutions and thought leadership to key stakeholders across pharma and biotech.

Read more about the EPA Congress here

Resource Centre

READ THE KEY FINDINGS FROM THE 2022 ACCESS TO MEDICINE INDEX

Some companies engaging in R&D for emerging infectious diseases, but pipeline mainly empty

15 November 2022

More access plans and strategies to expand access to more products, but with limited breadth and depth

15 November 2022

First voluntary licence for a cancer treatment is a promising sign for future expansion of access to innovative medicines

15 November 2022

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved